Welcure Drugs & Pharmaceuticals Ltd announced a 1:10 stock split, a 1:10 bonus issue, and an increase in authorised share capital to ₹196 crore. Post-split, paid-up capital remains ₹112.35 crore but bonus will raise it to ₹123.59 crore. The stock is up 97% from its 52-week low of ₹6.40 and has delivered 630% 5-year returns.